期刊文献+

阿卡波糖不良反应国外最新研究进展 被引量:28

Latest Study of Adverse Drug Reaction of Acarbose in the Foreign Countries
下载PDF
导出
摘要 通过系统回顾国外十余年来有关阿卡波糖不良反应的病例报道,全面分析上市后有关该药不良反应、安全性研究及与其他药物相互作用的情况,以指导临床医师合理使用阿卡波糖;同时,提出针对该药某些不良反应发生机制和药物相互作用机制积极开展上市后研究和制定有效的风险管理方案是该药上市后研究的重点与方向,从而为保证临床用药安全有效提供科学依据,同时也是延长产品生命周期与保持企业核心竞争力的重要途径。 By conducting a systematic review on adverse drug reaction (ADR) case reports of acarbose, analyzing its adverse drug reactions, safety and interaction with other drug, to pomote the rational use of acarbose. By conducting the post-market research in the mechanism of the ADR and the interaction to take effective risk management plan, which is the emphasis and direction of the research, to provide scientific theoretical basis for the medication safety. It's also an important way to extend the product life and hold the core competence.
出处 《中国药物警戒》 2009年第1期36-40,共5页 Chinese Journal of Pharmacovigilance
关键词 阿卡波糖 药品不良反应 研究 acarbose adverse drug reaction(ADR) study
  • 相关文献

参考文献10

  • 1Hollander P..Acarbose ADRs predominantly GI Safety profile of acarbose,an alpha-glucosidase inhibitor[].Drugs.1992
  • 2Mackay F,,Wilton L V,Pearce G,et al.Suspected ADRs of new drugs underreported Acarbose and gastrointestinal intolerance Pharmacoe[].Pidemiology and Drug Safety.1997
  • 3SADRAC.Two years on the Swedish market ADR reviews[].Bulletin from SADRAC.1997
  • 4Andrade R J,,Lucena M I,Rodriguez Mendizabal M.Hepatic injury caused by acarbose[].Annals of Internal Medicine.1996
  • 5Poszepczynska Guigne E,,Viguier M,Assier H,et al.Serious Pustulose exanthematique aigue generalisee induite par des medicaments a faible absorption intestinale:l‘acarbose et la nystatine[].Annales de Dermatologie et de Venereologie.2003
  • 6Piche T,,Raimondi V,Schneider S,et al.Acarbose and lym-phocytic colitis[].The Lancet.2000
  • 7Nishii Y,,Aizawa T,Hashizume K Acarbose.Ileus:case report.Ileus:a rare side effect of acarbose[].Diabetes Care.1996
  • 8Scheen A J,,Lefebvre P J.Possible interactions with antihyper-glycaemic agents:drug interactions of clinical importance[].Drug Safety.1995
  • 9Morreale A P,,Janetzky K.Probable interaction of warfarin and acarbose[].American Journal of Health System Pharmacy.1997
  • 10Kortboyer J M,,Eckland D J A.Pioglitazone has low potential for drug interactions[].Diabetologia.1999

同被引文献201

引证文献28

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部